Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
National Institute of Biomedical Research · Instituut voor Tropische Geneeskunde · +29 more institutions
Abstract
Outbreaks of monkeypox (mpox) have historically resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MPXV in West Africa. In 2022, subclade IIb caused a global epidemic linked to transmission through sexual contact. Here we describe the epidemiological and genomic features of an mpox outbreak in a mining region in eastern Democratic Republic of the Congo, caused by clade I MPXV. Surveillance data collected between September 2023 and January 2024 identified 241 suspected cases. Genomic analysis demonstrates a distinct clade I lineage divergent from previously circulating strains in the Democratic Republic of the Congo. Of the 108 polymerase chain reaction-confirmed…
Citation impact
- FWCI
- 92.79
- Percentile
- 100%
- References
- 25
Authors
45- EHEmmanuel Hasivirwe Vakaniaki
National Institute of Biomedical Research, Instituut voor Tropische Geneeskunde
- CKCris Kacita
Ministry of Public Health
- EKEddy Kinganda-Lusamaki
Inserm, University of Kinshasa, National Institute of Biomedical Research, Institute for Sustainable Development, Institut de Recherche pour le Développement
- ÁOÁine O’Toole
University of Edinburgh
- TWTony Wawina-Bokalanga
University of Kinshasa, National Institute of Biomedical Research, Instituut voor Tropische Geneeskunde
Topics & keywords
- Clade
- Monkeypox
- Outbreak
- Transmission (telecommunications)
- Lineage (genetic)
- Subclade
- Virology
- Biology
Funding
- UDU.S. Department of Defense
- UDU.S. Department of AgricultureAward: 20230048
- WHWorld Health Organization
- UOUniversity of Pittsburgh
- CWCase Western Reserve University
- WTWellcome TrustAwards: Z/17/Z, 206298/Z/17/Z, 206298
- IDInstitut de Recherche pour le Développement
- IDInternational Development Research CentreAward: MRR-184813
- FWFonds Wetenschappelijk OnderzoekAward: G096222N
- USUniversiteit Stellenbosch
- VRVlaamse regeringAward: G096222N
- NINational Institutes of HealthAward: 1D43TW010937-01A1
- DTDefense Threat Reduction Agency
- CICanadian Institutes of Health ResearchAward: MRR-184813
- NINational Institute of Allergy and Infectious DiseasesAward: 5U01AI096299-13
- FIFogarty International CenterAwards: R25TW011217, 1D43TW010937-01A1, D43TW010937